Stock listing

Cannara Biotech, Inc.

Selected listing: LOVE · TSX · CAD · CA

Cannara Biotech, Inc. (TSX:LOVE), Process Industries. Latest release Oct 5, 2026: Cannara Expands International Supply Agreement with Curaleaf.

LOVE:TSXCADCAUpdated October 3, 2026

Ticker: TSX:LOVE
Asset type: Stock
Sector: Process Industries
Industry: Agricultural Commodities/Milling
Exchange: TSX
Currency: CAD

About Cannara Biotech, Inc.

Cannara Biotech, Inc. is a Canadian public company focused on the cannabis industry, trading under the ticker LOVE. The company aims to leverage its expertise to capitalize on the growing demand in the market.

Latest news from Cannara Biotech, Inc.

Cannara Expands International Supply Agreement with Curaleaf

October 5, 2026

Cannara Expands Financing to an $80 Million Syndicated Credit Facility with BMO and TD Bank, Further Strengthening Its Financial Foundation for Continued Growth

September 10, 2026

Cannara Appoints Nicholas Fozard as Chief Financial Officer

September 1, 2026

Cannara Establishes Automatic Share Purchase Plan

August 13, 2026

Cannara Announces Normal Course Issuer Bid

July 22, 2026

All Cannara Biotech, Inc. news →

Events

Replays

Cannara Biotech Inc. (LOVE) Q3 2026 Earnings Call
Wed, Jul 15, 2026 · 11:00 AM ET
Watch
Cannara Biotech Inc. (LOVE) Q2 2026 Earnings Call
Tue, Apr 14, 2026 · 10:00 AM ET
Watch
Cannara Biotech Inc. (LOVE) Q3 2025 Earnings Call
Mon, Jul 28, 2025 · 11:00 AM ET
Watch

Research Cannara Biotech, Inc.

Cannara Biotech, Inc. company profile

View the public company page for Cannara Biotech, Inc. on 6ix.

Cannara Biotech, Inc. news

Read company news and market updates connected to Cannara Biotech, Inc..

Cannara Biotech, Inc. investor events

Find investor webinars, events, and replay context for Cannara Biotech, Inc..